Check back often to find the latest news on AgeneBio and our pipeline of multiple candidates.
September 15, 2015
Hopkins, AgeneBio to launch trial of Alzheimer’s drug in partnership with NIH
“What this could mean for thousands of patients is they may never cross over into full-blown Alzheimer’s dementia,” said Jerry McLaughlin, CEO of AgeneBio, the Baltimore company founded by a Hopkins researcher who discovered that the drug might…
